CSPC PHARMACEUTICAL GROUP LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.48 HKD | -1.82% |
|
+7.11% | -10.74% |
ETFs positioned on CSPC Pharmaceutical Group Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 4.05% | 2 M€ | -14.86% | - | |
| 2.02% | 4 M€ | -27.92% | ||
| 1.07% | 3 M€ | +0.62% | - | |
| 0.99% | 2 M€ | -14.14% | ||
| 0.86% | 4 M€ | -11.56% | ||
| 0.53% | 18 M€ | +4.53% | ||
| 0.26% | 11 M€ | +2.69% | ||
| 0.23% | 35 M€ | -5.85% | - | |
| 0.23% | 1 M€ | +3.49% | - | |
| 0.23% | 3 M€ | -.--% | - | |
| 0.10% | 441 M€ | +5.00% | - | |
| 0.10% | 2,808 M€ | +6.41% | - | |
| 0.10% | 149 M€ | +3.21% | - | |
| 0.09% | 117 M€ | +1.01% | - | |
| 0.08% | 4 M€ | -4.41% | - | |
| 0.05% | 0 M€ | 0.00% | - | |
| 0.04% | 31 M€ | +4.15% | - | |
| 0.03% | 7 M€ | +0.11% | - | |
| 0.02% | 389 M€ | +6.81% | - | |
| 0.02% | 34 M€ | +6.75% | - | |
| 0.01% | 7 M€ | +2.17% | - | |
| 0.01% | 39 M€ | +4.26% | - | |
| 0.01% | 302 M€ | +4.26% | - | |
| 0.01% | 17 M€ | +1.67% | - | |
| 0.01% | 34 M€ | +2.43% | - | |
| 0.01% | 108 M€ | +2.11% | - | |
| 0.01% | 147 M€ | +4.88% | - |
CSPC Pharmaceutical Group Ltd. specializes in the development, manufacture and marketing of pharmaceutical products. Net sames by category of products break down as follows:
- drugs (78.7%): innovative drugs (62.5% of sales) and common generic drugs (37.5%);
- vitamin C (10.1%);
- antibiotics (6.2%);
- other (5%): including anhydrous and raw caffeine.
Net sales are distributed geographically as follows: China (82.8%), Asia (7.2%), Europe (4.6%), the Americas (4.4%) and others (1%).
Sector
Pharmaceuticals
Calendar
2024-05-21
- Q1 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
6.6
HKD
Average target price
9.348
HKD
Spread / Average Target
+41.64%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -10.74% | 9.99B | |
| +34.50% | 664B | |
| +29.21% | 567B | |
| -7.09% | 354B | |
| +19.53% | 330B | |
| +4.63% | 286B | |
| +13.49% | 234B | |
| +5.26% | 199B | |
| -9.90% | 196B | |
| -4.79% | 148B |
- Stock Market
- Equities
- 1093 Stock
- Funds and ETFs CSPC Pharmaceutical Group Ltd.
